{
  "folder": "IC-027",
  "content": "{{knowledge objective\n|Identifiant=OIC-027-17-A\n|Item_parent=Prevention of foetal risks: infection, drugs, toxic substances, irradiation\n|Item_parent_short=Prevention of foetal risks: infection, drugs, toxic substances, irradiation\n|Rank=A\n|Title=Human immunodeficiency virus (HIV): knowing the elements of prevention through screening\n|Description=Knowing the methods of maternal screening\n|Rubric=Management\n|Contributors=Alexandre Vivanti, Philippe Deruelle\n|Ordre=17}}\nFor the sake of the child (and the mother), the mother's [[Interpretation of an SD-236 serology result|HIV status]] should be known. Screening should be offered systematically at the beginning of pregnancy (at the time of notification), even if it is not compulsory.",
  "question": {
    "question": "What is the recommended approach for maternal screening during pregnancy?",
    "option_a": "Offer screening at the end of pregnancy, not at the beginning.",
    "option_b": "Screening should only be offered to women who have a high-risk profile.",
    "option_c": "Screening should only be offered to women who have a high-risk profile, and only if the mother's HIV status is confirmed.",
    "option_d": "Screening should only be offered to women who have a high-risk profile, and only if the mother's HIV status is confirmed, and the mother's HIV status is confirmed.",
    "correct_option": "option_b"
  }
}